source
- Dutch court blocks Merck's subcutaneous Keytruda in several European marketsA Dutch court has ruled that Merck infringed a patent covering a subcutaneous formulation of its cancer drug Keytruda. The decision requires the company to stop manufacturing and marketing that ver…
- Forbion secures $2.6 billion in its biggest European venture fund to dateForbion, a leading European venture capital firm, announced it has closed a $2.6 billion fund, the largest it has raised and among the biggest recent funds in the region. The new capital will be d…